Sanofi’s COVID-19 Vaccine With Translate Bio Delayed Until Next Year – Report

Sanofi’s CEO, Paul Hudson, said that the mRNA-based (messenger Ribonucleic acid) COVID-19 vaccine developed by the pharma giant and Translate Bio will not be ready this year, according to a Reuters report, citing the French newspaper Le Journal du Dimanche.